Prestige Consumer Healthcare Inc. reported company-record revenues of $1.13bn for its latest fiscal year, in no small part due to its Hydralyte hydration line leading nearly 30% sales growth in its international markets.
Expanding sales of its Hydralyte line to the rapidly growing sports beverage market in the US might seem a likely target for PCH